Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Organ Transplantation | 6 | 2024 | 1174 | 1.530 |
Why?
|
Kidney Transplantation | 9 | 2024 | 4270 | 1.450 |
Why?
|
Proteinuria | 3 | 2024 | 607 | 1.060 |
Why?
|
Measles | 1 | 2024 | 180 | 0.780 |
Why?
|
Disease Outbreaks | 2 | 2024 | 1759 | 0.570 |
Why?
|
Bone Diseases | 1 | 2021 | 411 | 0.560 |
Why?
|
Graft Rejection | 5 | 2024 | 4499 | 0.450 |
Why?
|
Monitoring, Physiologic | 1 | 2022 | 1792 | 0.450 |
Why?
|
Antibodies, Monoclonal | 2 | 2023 | 9249 | 0.320 |
Why?
|
Fractures, Bone | 1 | 2021 | 2041 | 0.310 |
Why?
|
Antibody Formation | 2 | 2023 | 1391 | 0.290 |
Why?
|
Glomerular Filtration Rate | 3 | 2024 | 2233 | 0.270 |
Why?
|
Antibodies, Viral | 3 | 2023 | 3211 | 0.270 |
Why?
|
Measles Vaccine | 1 | 2024 | 79 | 0.220 |
Why?
|
Glomerulonephritis, IGA | 1 | 2024 | 62 | 0.210 |
Why?
|
Glomerulonephritis, Membranous | 1 | 2024 | 84 | 0.210 |
Why?
|
Budesonide | 1 | 2024 | 163 | 0.200 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2022 | 126 | 0.190 |
Why?
|
Isoantibodies | 2 | 2022 | 681 | 0.180 |
Why?
|
Tacrolimus | 1 | 2024 | 753 | 0.180 |
Why?
|
Vaccination | 2 | 2024 | 3426 | 0.180 |
Why?
|
Delayed-Action Preparations | 1 | 2024 | 967 | 0.170 |
Why?
|
Interleukin-2 | 2 | 2024 | 1896 | 0.170 |
Why?
|
Minerals | 1 | 2021 | 278 | 0.160 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 621 | 0.160 |
Why?
|
Hepatitis B | 1 | 2023 | 707 | 0.150 |
Why?
|
Immunity, Humoral | 1 | 2022 | 605 | 0.140 |
Why?
|
Transplantation, Homologous | 2 | 2024 | 4860 | 0.140 |
Why?
|
Piracetam | 1 | 2016 | 88 | 0.130 |
Why?
|
Immunity, Cellular | 1 | 2022 | 1555 | 0.130 |
Why?
|
Neurocysticercosis | 1 | 2016 | 88 | 0.120 |
Why?
|
Humans | 19 | 2024 | 765968 | 0.110 |
Why?
|
Tissue Donors | 1 | 2023 | 2395 | 0.110 |
Why?
|
Cholangiocarcinoma | 1 | 2019 | 578 | 0.110 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 2010 | 0.100 |
Why?
|
Graft Survival | 4 | 2024 | 3890 | 0.100 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2019 | 617 | 0.100 |
Why?
|
Immunosuppressive Agents | 1 | 2024 | 4209 | 0.100 |
Why?
|
Prospective Studies | 4 | 2024 | 54802 | 0.090 |
Why?
|
Recurrence | 1 | 2024 | 8501 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2024 | 2310 | 0.080 |
Why?
|
Retrospective Studies | 6 | 2024 | 81514 | 0.080 |
Why?
|
Bone Density | 1 | 2021 | 3491 | 0.070 |
Why?
|
Carcinoma | 1 | 2019 | 2312 | 0.070 |
Why?
|
Disease Progression | 1 | 2024 | 13632 | 0.070 |
Why?
|
Anticonvulsants | 1 | 2016 | 1921 | 0.070 |
Why?
|
Plasmapheresis | 1 | 2022 | 205 | 0.050 |
Why?
|
Kidney Function Tests | 1 | 2024 | 683 | 0.050 |
Why?
|
Epilepsy | 1 | 2016 | 3320 | 0.040 |
Why?
|
Antilymphocyte Serum | 1 | 2022 | 493 | 0.040 |
Why?
|
Germinal Center | 1 | 2022 | 379 | 0.040 |
Why?
|
Qatar | 1 | 2016 | 40 | 0.030 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2022 | 975 | 0.030 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2019 | 335 | 0.030 |
Why?
|
Middle Aged | 4 | 2024 | 223009 | 0.030 |
Why?
|
Hepatitis B, Chronic | 1 | 2019 | 412 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1831 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2024 | 2132 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2417 | 0.030 |
Why?
|
Male | 5 | 2024 | 363698 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 2019 | 1078 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22340 | 0.030 |
Why?
|
Aged | 2 | 2024 | 171117 | 0.030 |
Why?
|
Female | 5 | 2024 | 396112 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12976 | 0.030 |
Why?
|
Kidney Failure, Chronic | 1 | 2024 | 2495 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8733 | 0.020 |
Why?
|
Adult | 5 | 2024 | 223044 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3111 | 0.020 |
Why?
|
Survival Rate | 1 | 2024 | 12795 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7066 | 0.020 |
Why?
|
Mice | 2 | 2024 | 81819 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21480 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2024 | 65188 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4353 | 0.010 |
Why?
|
Prognosis | 1 | 2024 | 29922 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2024 | 39193 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2024 | 15747 | 0.010 |
Why?
|
Animals | 2 | 2024 | 168764 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9373 | 0.010 |
Why?
|
Risk Factors | 1 | 2024 | 74840 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 59889 | 0.010 |
Why?
|
Concepts
(82)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(29)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_